HTA - 15/57/143

MS-STAT2: A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo in secondary progressive multiple sclerosis, in slowing the progression of disability

Project title: MS-STAT2: A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo in secondary progressive multiple sclerosis, in slowing the progression of disability

Call to action: 15/57 15/57 HTA CET Open Call, HTA EOI to Full Form, closing 3 September 2015

Research type: Primary Research

Chief investigator: Professor Jeremy Chataway

Contractor: University College London

Cost: £4,445,242.36

Co-investigators: Dr Jennifer Nicholas, Mr Stuart Nixon, Mrs Marie Braisher, Mrs Susan Tebbs, Professor Alan Thompson, Professor Christopher Frost, Professor Gavin Giovannoni, Professor Helen Ford, Professor John Greenwood, Professor Olga Ciccarelli, Professor Richard Nicholas, Professor Siddharthan Chandran, Professor Sue Pavitt.

Started: March 2017 | Status: Research in progress

ISRCTN: 82598726

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.